These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 2433213

  • 1. Monoclonal anti-IL 1 is directed against a common site of human IL 1 alpha and IL 1 beta.
    Luger TA, Danner M, Köck A.
    Immunobiology; 1986 Sep; 172(3-5):346-56. PubMed ID: 2433213
    [Abstract] [Full Text] [Related]

  • 2. Characterization of immunoregulatory cytokines produced by epidermal cells.
    Luger TA, Köck A, Danner M.
    Scand J Immunol; 1985 May; 21(5):455-62. PubMed ID: 3890150
    [Abstract] [Full Text] [Related]

  • 3. Characterization of a monoclonal antibody directed against the biologically active site of human interleukin 1.
    Köck A, Danner M, Stadler BM, Luger TA.
    J Exp Med; 1986 Feb 01; 163(2):463-8. PubMed ID: 2418147
    [Abstract] [Full Text] [Related]

  • 4. Epidermal interleukin-1 is increased in cutaneous T-cell lymphoma.
    Tron VA, Rosenthal D, Sauder DN.
    J Invest Dermatol; 1988 Mar 01; 90(3):378-81. PubMed ID: 3279133
    [Abstract] [Full Text] [Related]

  • 5. Isolation and characterization of monoclonal antibodies to recombinant bovine interleukin-1 beta.
    Reddy DN, Chitko-McKown CG, Reddy PG, Minocha HC, Blecha F.
    Vet Immunol Immunopathol; 1993 Feb 01; 36(1):17-29. PubMed ID: 7680508
    [Abstract] [Full Text] [Related]

  • 6. Localization of human mononuclear cell interleukin 1.
    Conlon PJ, Grabstein KH, Alpert A, Prickett KS, Hopp TP, Gillis S.
    J Immunol; 1987 Jul 01; 139(1):98-102. PubMed ID: 3495602
    [Abstract] [Full Text] [Related]

  • 7. Development and characterization of two neutralizing monoclonal antibodies to human interleukin-1 alpha.
    Stya M, Dower SK, Prickett KS, Gillis S, Conlon PJ.
    J Biol Response Mod; 1988 Apr 01; 7(2):162-72. PubMed ID: 3258906
    [Abstract] [Full Text] [Related]

  • 8. Monoclonal antibodies to human recombinant interleukin 1 (IL 1)beta: quantitation of IL 1 beta and inhibition of biological activity.
    Kenney JS, Masada MP, Eugui EM, Delustro BM, Mulkins MA, Allison AC.
    J Immunol; 1987 Jun 15; 138(12):4236-42. PubMed ID: 2438338
    [Abstract] [Full Text] [Related]

  • 9. Preparation and characterization of polyclonal and monoclonal antibodies against human interleukin 1 alpha (IL 1 alpha).
    Kasahara T, Mukaida N, Shinomiya H, Imai M, Matsushima K, Wakasugi H, Nakano K.
    J Immunol; 1987 Mar 15; 138(6):1804-12. PubMed ID: 3546497
    [Abstract] [Full Text] [Related]

  • 10. Modulation of IL-1 alpha, IL-1 beta, and 25K Mr non-IL-1 activity released by human mononuclear cells.
    Sandborg CI, Berman MA, Imfeld KL, Zaldivar F, Masada MP, Kenney JS.
    J Leukoc Biol; 1989 Nov 15; 46(5):417-27. PubMed ID: 2509610
    [Abstract] [Full Text] [Related]

  • 11. Role of the Ly 1 antigen in interleukin 1-induced thymocyte activation.
    Lögdberg L, Shevach EM.
    Eur J Immunol; 1985 Oct 15; 15(10):1007-13. PubMed ID: 3876939
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components.
    Zhang Y, Doerfler M, Lee TC, Guillemin B, Rom WN.
    J Clin Invest; 1993 May 15; 91(5):2076-83. PubMed ID: 7683696
    [Abstract] [Full Text] [Related]

  • 13. Species differences in human and rat islet sensitivity to human cytokines. Monoclonal anti-interleukin-1 (IL-1) influences on direct and indirect IL-1-mediated islet effects.
    Kawahara DJ, Kenney JS.
    Cytokine; 1991 Mar 15; 3(2):117-24. PubMed ID: 1888882
    [Abstract] [Full Text] [Related]

  • 14. Properties of murine and human epidermal cell-derived thymocyte-activating factor.
    Luger TA, Sztein MB, Schmidt JA, Murphy P, Grabner G, Oppenheim JJ.
    Fed Proc; 1983 Jul 15; 42(10):2772-6. PubMed ID: 6602721
    [Abstract] [Full Text] [Related]

  • 15. A new role for epidermal cell-derived thymocyte activating factor/IL-1 as an antagonist for distinct epidermal cell function.
    Swope VB, Abdel-Malek ZA, Sauder DN, Nordlund JJ.
    J Immunol; 1989 Mar 15; 142(6):1943-9. PubMed ID: 2466081
    [Abstract] [Full Text] [Related]

  • 16. A monoclonal antibody recognizing 68- to 75-kilodalton protein(s) associated with the human IL-1 receptor.
    Bensimon C, Wakasugi H, Wakasugi N, Jitsukawa S, Tursz T.
    J Immunol; 1989 Apr 01; 142(7):2290-8. PubMed ID: 2522480
    [Abstract] [Full Text] [Related]

  • 17. An IL-1 inhibitor from human monocytes. Production and characterization of biologic properties.
    Arend WP, Joslin FG, Thompson RC, Hannum CH.
    J Immunol; 1989 Sep 15; 143(6):1851-8. PubMed ID: 2528582
    [Abstract] [Full Text] [Related]

  • 18. Biologic properties of epidermal cell thymocyte-activating factor (ETAF).
    Sauder DN.
    J Invest Dermatol; 1985 Jul 15; 85(1 Suppl):176s-179s. PubMed ID: 3874245
    [Abstract] [Full Text] [Related]

  • 19. [Thymocyte activating factors in human gingival fibroblast cultures stimulated by oral Bacteroides lipopolysaccharides: induction, identification and modification by various cytokines].
    Mihara J.
    Osaka Daigaku Shigaku Zasshi; 1990 Jun 15; 35(1):22-40. PubMed ID: 2135406
    [Abstract] [Full Text] [Related]

  • 20. Functional and molecular characterization of a monoclonal antibody against the 165-186 peptide of human IL-1 beta.
    Herzbeck H, Blum B, Rönspeck W, Frenzel B, Brandt E, Ulmer AJ, Flad HD.
    Scand J Immunol; 1989 Nov 15; 30(5):549-62. PubMed ID: 2587933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.